Characterization of regulatory T cells in obese omental adipose tissue in humans
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Obesity‐associated visceral adipose tissue (AT) inflammation promotes insulin resistance and type 2 diabetes (T2D). In mice, lean visceral AT is populated with anti‐inflammatory cells, notably regulatory T cells (Tregs) expressing the IL‐33 receptor ST2. Conversely, obese AT contains fewer Tregs and more proinflammatory cells. In humans, however, there is limited evidence for a similar pattern of obesity‐associated immunomodulation. We used flow cytometry and mRNA quantification to characterize human omental AT in 29 obese subjects, 18 of whom had T2D. Patients with T2D had increased proportions of inflammatory cells, including M1 macrophages, with positive correlations to body mass index. In contrast, Treg frequencies negatively correlated to body mass index but were comparable between T2D and non‐T2D individuals. Compared to human thymic Tregs, omental AT Tregs expressed similar levels of FOXP3, CD25, IKZF2 , and CTLA4 , but higher levels of PPARG , CCR4 , PRDM1 , and CXCL2 . ST2, however, was not detectable on omental AT Tregs from lean or obese subjects. This is the first comprehensive investigation into how omental AT immunity changes with obesity and T2D in humans, revealing important similarities and differences to paradigms in mice. These data increase our understanding of how pathways of immune regulation could be targeted to ameliorate AT inflammation in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The data included show the analysis of Tregs in healthy individuals but these gating strategies can also be used to analyze Tregs in patients with a variety of diseases [371, 387, 408].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [387]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells
Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., Benoist, C., & Mathis, D. (2012) · Nature · doi:10.1038/nature11132 · Cited by 1,143
The alarmin IL-33 promotes regulatory T-cell function in the intestine
Schiering, C., Krausgruber, T., Chomka, A., Fröhlich, A., Adelmann, K., Wohlfert, E. A., Pott, J., Griseri, T., Bollrath, J., Hegazy, A. N., et al. (2014) · Nature · doi:10.1038/nature13577 · Cited by 1,005
Wentworth, J. M., Naselli, G., Brown, W. A., Doyle, L., Phipson, B., Smyth, G. K., Wabitsch, M., O'Brien, P. E., & Harrison, L. C. (2010) · Diabetes · doi:10.2337/db09-0287 · Cited by 603
Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.
Boyko, E. J., Fujimoto, W. Y., Leonetti, D. L., & Newell-Morris, L. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.465 · Cited by 579
Zeyda, M., Farmer, D., Todoric, J., Aszmann, O., Speiser, M., Györi, G., Zlabinger, G. J., & Stulnig, T. M. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803632 · Cited by 558
Vasanthakumar, A., Moro, K., Xin, A., Liao, Y., Gloury, R., Kawamoto, S., Fagarasan, S., Mielke, L. A., Afshar-Sterle, S., Masters, S. L., et al. (2015) · Nature Immunology · doi:10.1038/ni.3085 · Cited by 555
Guidelines for the use of flow cytometry and cell sorting in immunological studies *
Cossarizza, A., Chang, H., Radbruch, A., Akdis, M., Andrä, I., Annunziato, F., Bacher, P., Barnaba, V., Battistini, L., Bauer, W. M., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646632 · Cited by 542
Spencer, M., Yao-Borengasser, A., Unal, R., Rasouli, N., Gurley, C. M., Zhu, B., Peterson, C. A., & Kern, P. A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00329.2010 · Cited by 439
Bertola, A., Ciucci, T., Rousseau, D., Bourlier, V., Duffaut, C., Bonnafous, S., Blin-Wakkach, C., Anty, R., Iannelli, A., Gugenheim, J., et al. (2012) · Diabetes · doi:10.2337/db11-1274 · Cited by 399
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Self-citationImmunometabolism: From basic mechanisms to translation
Makowski, L., Chaib, M., & Rathmell, J. C. (2020) · Immunological Reviews · doi:10.1111/imr.12858 · Cited by 374
Tissue regulatory T cells: regulatory chameleons
Muñoz-Rojas, A. R., & Mathis, D. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00519-w · Cited by 281
Delacher, M., Simon, M., Sanderink, L., Hotz-Wagenblatt, A., Wuttke, M., Schambeck, K., Schmidleithner, L., Bittner, S., Pant, A., Ritter, U., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.03.007 · Cited by 164
Immunometabolic mechanisms of heart failure with preserved ejection fraction
Schiattarella, G. G., Alcaide, P., Condorelli, G., Gillette, T. G., Heymans, S. R. B., Jones, E. A. V., Kallikourdis, M., Lichtman, A. H., Marelli‐Berg, F. M., Shah, S. J., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00032-w · Cited by 143
Specialized immune responses in the peritoneal cavity and omentum
Liu, M., Silva-Sánchez, A., Randall, T. D., & Meza‐Perez, S. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mir0720-271rr · Cited by 147
Type 2 Diabetes: How Much of an Autoimmune Disease?
de Candia, P., Prattichizzo, F., Garavelli, S., Rosa, V. D., Galgani, M., Rella, F. D., Spagnuolo, M. I., Colamatteo, A., Fusco, C., Micillo, T., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00451 · Cited by 130
“Compared to thymic population, omental AT Treg cells expressed higher levels of PPAR-γ, but failed to show any detectable expression of IL-33 receptor, ST2 (118), thus contradicting a previous report (112).”
ResultLi, C., Wang, G., Sivasami, P., Ramírez, R. N., Zhang, Y., Benoist, C. O., & Mathis, D. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.06.007 · Cited by 123
Resident and migratory adipose immune cells control systemic metabolism and thermogenesis
Man, K., Kallies, A., & Vasanthakumar, A. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00804-7 · Cited by 128
“For example, our data suggested that IL-33 signaling plays a role in mouse and human adipose tissue Treg cells [46], while others have failed to identify ST2+ Treg cells in human adipose tissue [141].”
BackgroundTreg cell therapy: How cell heterogeneity can make the difference
Giganti, G., Atif, M., Mohseni, Y., Mastronicola, D., Grageda, N., Povoleri, G. A., Miyara, M., & Scottà, C. (2021) · European Journal of Immunology · doi:10.1002/eji.201948131 · Cited by 82
Harnessing the biology of regulatory T cells to treat disease
Wardell, C. M., Boardman, D. A., & Levings, M. K. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01089-x · Cited by 100
“In terms of obesity, adipose tissue in overweight mice and humans is characterized by low-grade inflammation and decreased T reg cell frequency and function relative to lean individuals 99–101 .”
Self-citationPacella, I., & Piconese, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01889 · Cited by 83
“According to recent data, Tregs express PPARγ also in the omental adipose tissue of humans, and Treg frequency is moderately increased in that tissue compared to the peripheral blood; however, no significant variation was observed in obese subjects or in type-2 diabetes patients compared to healthy controls (89).”
BackgroundShantaram, D., Hoyd, R., Blaszczak, A. M., Antwi, L., Jalilvand, A., Wright, V. P., Liu, J., Smith, A. J., Bradley, D. P., Lafuse, W. P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48935-5 · Cited by 81
Innate Control of Tissue-Reparative Human Regulatory T Cells
Lam, A. J., MacDonald, K. N., Pesenacker, A. M., Juvet, S. C., Morishita, K. A., Bressler, B., iGenoMed Consortium, Pan, J. G., Sidhu, S. S., Rioux, J. D., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801330 · Cited by 47
“We also failed to detect ST2 Tregs in human omental adipose tissue from lean or obese subjects (44).”
ResultSelf-citationT reg–specific insulin receptor deletion prevents diet-induced and age-associated metabolic syndrome
Wu, D., Wong, C. K., Han, J. M., Orban, P. C., Huang, Q., Gillies, J., Mojibian, M., Gibson, W. T., & Levings, M. K. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191542 · Cited by 43
“, 2015) and humans (Wu et al., 2019), obese AT contains reduced proportions of VAT T regs, and therapies that reverse obesity-associated VAT T reg loss improve systemic insulin sensitivity (Feuerer et al.”
BackgroundSelf-citationStability and Maintenance of Foxp3+ Treg Cells in Non-lymphoid Microenvironments
Korn, T., & Muschaweckh, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02634 · Cited by 46
Ratter-Rieck, J. M., Maalmi, H., Trenkamp, S., Zaharia, O., Rathmann, W., Schloot, N. C., Straßburger, K., Szendroedi, J., Herder, C., & Roden, M. (2021) · Diabetes · doi:10.2337/db21-0364 · Cited by 47
“HDL cholesterol, mg/dL 59 (48, 71) 55 (45, 59) 42 (35, 48) 43 (37, 51) 49 (41, 57) <0.”
BackgroundOrchestration of the Adipose Tissue Immune Landscape by Adipocytes
Bradley, D. P., Deng, T., Shantaram, D., & Hsueh, W. A. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042222-024353 · Cited by 46
Gut Microbiota‐Butyrate‐PPARγ Axis Modulates Adipose Regulatory T Cell Population
Chen, B., Guan, L., Wu, C., Gong, Y., Wu, L., Zhang, M., Cao, Z., Chen, Y., Yang, C., Wang, B., et al. (2025) · Advanced Science · doi:10.1002/advs.202411086 · Cited by 52
Implications of inflammatory states on dysfunctional immune responses in aging and obesity
Thomas, A. L., Alarcon, P. C., Divanovic, S., Chougnet, C. A., Hildeman, D. A., & Moreno-Fernandez, M. E. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.732414 · Cited by 35
“Changes in the adipose tissue microenvironment result in increased volume of inflammatory cells and subsequent secretion of inflammatory mediators (e.g., Leptin, IL-6, IL-1β) (Skurk et al., 2007; Strissel et al., 2007; Grant and Dixit, 2015; Wueest and Konrad, 2018).”
BackgroundKeeping It Local in Metabolic Disease: Adipose Tissue Paracrine Signaling and Insulin Resistance
KAHN, D. E., & Bergman, B. C. (2022) · Diabetes · doi:10.2337/dbi21-0020 · Cited by 41
Elkins, C., Ye, C., Sivasami, P., Mulpur, R., Diaz-Saldana, P. P., Peng, A., Xu, M., Chiang, Y.-P., Moll, S., Rivera-Rodriguez, D. E., et al. (2025) · Science immunology · doi:10.1126/sciimmunol.adl4909 · Cited by 30
Transcriptional regulation of Treg homeostasis and functional specification
Wang, K., & Fu, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03534-7 · Cited by 37
T cell phenotypes associated with insulin resistance: results from the Berlin Aging Study II
Sbierski‐Kind, J., Goldeck, D., Buchmann, N., Spranger, J., Volk, H., Steinhagen‐Thiessen, E., Pawelec, G., Demuth, I., & Spira, D. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00211-y · Cited by 28
Becker, M., Dirschl, S. M., Scherm, M. G., Serr, I., & Daniel, C. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.019 · Cited by 24
HFpEF and MASLD: converging mechanisms and clinical implications
Capone, F., Häseli, S. P., Liu, L., Strocchi, S., Langenberg, C., Lusis, A. J., Pietzner, M., Muoio, D. M., Rider, O. J., Raman, B., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01257-z · Cited by 37
Liu, L., Hu, J., Wang, Y., Lei, H. C., & Xu, D. (2021) · Adipocyte · doi:10.1080/21623945.2021.1876375 · Cited by 30
“In addition to these results in animal experiments, Wu et al [13].”
ResultKong, L., Chen, X.-H., Sun, Q., Zhang, K., Xu, L., Ding, L., Zhou, Y., Zhang, Z.-B., Lin, J., & Gao, P. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112078 · Cited by 25
The tumor immune microenvironment in peritoneal carcinomatosis
Demuytere, J., Ernst, S., van Ovost, J., Cosyns, S., & Ceelen, W. P. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.015 · Cited by 23
Jugder, B., Park, E., Du, L., Jawale, C. V., Popov, N., Guo, Z., Bednar, K. J., & Ort, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1650451 · Cited by 23
“Human adipose tissue Tregs also express high levels of PPAR g and immunomodulatory genes like PRDM1 (encoding BLIMP1) and CCR4 , but show variability in ST2 expression across studies (7, 248).”
Deciphering Visceral Adipose Tissue Regulatory T Cells: Key Contributors to Metabolic Health
Elkins, C., & Li, C.-R. (2024) · Immunological Reviews · doi:10.1111/imr.13336 · Cited by 18
“64 However, unlike eVAT Tregs, omVAT Tregs do not show elevated expression of KLRG1 , AREG , or ST2, 64 indicating key phenotypic differences between murine and human VAT Tregs.”
Tissue adaptation of regulatory T cells in adipose tissue
Yu, Y., Bai, H., Wu, F., Chen, J., Li, B., & Li, Y. (2022) · European Journal of Immunology · doi:10.1002/eji.202149527 · Cited by 18
CD8+ Treg cells play a role in the obesity-associated insulin resistance
Barbosa, P., Pinho, A. C. O., Lázaro, A., Silva, D., Paula, D., Campos, J., Tralhão, J. G., Pereira, M. J., Paiva, A. A., Laranjeira, P., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122306 · Cited by 17
“Interestingly, Wu and collaborators (2019) re-ported a reduction of CD4 + Treg cells in the VAT of T2D patients [34], while no differences have been observed by our group for this cell population (our unpublished data).”
BackgroundSchroeter, C. B., Huntemann, N., Böck, S., Nelke, C., Kremer, D., Pfeffer, K., Meuth, S. G., & Ruck, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.747143 · Cited by 16
Adipose Tissue T Regulatory Cells: Implications for Health and Disease
Bradley, D. P., Shantaram, D., Smith, A. J., & Hsueh, W. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6407-9_8 · Cited by 14
Metabolic syndrome and its effect on immune cells in apical periodontitis- a narrative review
Zhu, Y. X., & Shrestha, A. (2025) · Clinical Oral Investigations · doi:10.1007/s00784-025-06161-3 · Cited by 13
“Obesity is known to affect T cells populations, with significantly lower levels of Tregs observed in obese patients when compared to healthy individuals [98].”
Cytokine and metabolic regulation of adipose tissue Tregs
Elkins, C., & Li, C.-R. (2022) · Immunometabolism · doi:10.1097/in9.0000000000000013 · Cited by 7
“Interestingly, they also observed omVAT Tregs highly expressed PPARG (PPARγ), consistent with findings in mice, but observed no detectable expression of ST2[44].”
ResultButyrate and tributyrin reduce LPS-induced inflammatory cytokine production from human visceral fat
Rafiei, H., Yeung, M., Kowalski, S., Li, M. Y., Harris, D. E., Chang, J. A., Nguyen, N. H., Yorke, E., Sampath, S., Hollman, S., et al. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01581-9 · Cited by 8
“To test the viability of the pieces of visceral fat, the pieces were minced with sterile scissors and digested according to methods adopted from Wu et al. [8] and Carswell et al. [9].”
Self-citationFeuerer, M., Gray, D. H. D., Rankin, L. C., Schmidleithner, L., & Liston, A. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082924-092651 · Cited by 10
Regulatory T cells: master orchestrators of immune tolerance and tissue homeostasis
Bluestone, J. A., Levings, M. K., Ramsdell, F. J., Rudensky, A. Y., Tang, Q., & Trzonkowski, P. (2026) · Frontiers in Science · doi:10.3389/fsci.2026.1792210 · Cited by 10
Self-citationMultifaceted roles of T cells in obesity and obesity‐related complications: A narrative review
Qi, X., Li, Z., Han, J., Liu, W., Xia, P., Cai, X., Liu, X., Liu, X., Zhang, J., & Yu, P. (2023) · Obesity Reviews · doi:10.1111/obr.13621 · Cited by 14
“However, this study has some contradictions: (1) Although it is inhibited by sST2, IL-33 is still highly expressed in individuals with obesity,(166) and (2) sST2 and IL-33 deletion does not ameliorate but induces obesity and metabolic disorders, consistent with the findings of a clinical trial that Tregs in the AT of…”
ResultSelf-citationGama, J. F. G., Pinheiro, D. F., da Silva, R. F., Quírico‐Santos, T., & Lagrota-Cândido, J. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03238-1 · Cited by 9
Pinho, A. C. O., Barbosa, P., Lázaro, A., Tralhão, J. G., Pereira, M. J., Paiva, A. A., Laranjeira, P., & Carvalho, E. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106911 · Cited by 6
Interleukin-33: Expression, regulation and function in adipose tissues
Chen, Q., Xiang, D., Liang, Y., Meng, H., Zhang, X., & Lü, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113285 · Cited by 5
Zhang, Y., & Fu, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1420499 · Cited by 4
The effect of regulatory T cells in Schistosoma-mediated protection against type 2 diabetes
Gao, Y.-R., Sun, X., Li, R., Tang, C., Zhang, R.-H., Zhu, Y., Li, X., & Pan, Q. (2021) · Acta Tropica · doi:10.1016/j.actatropica.2021.106073 · Cited by 4
Cha, J.-H., & Choi, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311688 · Cited by 2
Les cellules immunes résidentes du tissu adipeux
Zakaroff‐Girard, A., Belles, C., Umuhoza, F., Fontaine, J., & Bouloumié, A. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30092-6 · Cited by 2
Sarsenbayeva, A., Pereira, M. J., Jui, B. N., Ahmed, F., Dipta, P., Fanni, G., Almby, K. E., Kristófi, R., Hetty, S., & Eriksson, J. W. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4002214
The role of Themis in development of type 2 diabetesPreprint
Gascoigne, N. R. J., Wojciech, Ł., Prasad, M., Brzostek, J., Rybakin, V., Hoerter, J. A. H., Hou, B., Tung, D. W. H., Chua, Y. L., Ampudia, J., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7943370/v1
“However, examination of omental tissue from obese individuals reveals no signi�cant differences in Treg population size compared to non-obese counterparts 6,55 .”
Sbierski‐Kind, J., Goldeck, D., Buchmann, N., Spranger, J., Volk, H.-D., Steinhagen-Thiessen, E., Pawelec, G., Demuth, I., & Spira, D. (2020) · Figshare · doi:10.6084/m9.figshare.13467435
Грунина, М. Н., Dracheva, K. V., Izyumchenko, A. D., Николаевич, Г. И., Гараева, Л. А., Сурцукова, М. А., Anisimova, K. A., Тристановна, Б. Е., Balandov, S. G., Vasilevsky, D. I., et al. (2025) · Nanobiotechnology Reports · doi:10.1134/s2635167625600713
Kucharski, A. A., Brice, C. E., Hayes, N., Duddleston, K. N., & Kurtz, C. C. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1802487
Regulatory T cell function and engineering for next generation cell therapies
Zammit, N. W., Sassone‐Corsi, M., Zarin, P., Guo, T., Hoover, M. E., Repic, M., Uenishi, G. I., Moore, C. L., Gaddis, D. E., Bach, M. A., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1887951
“Loss of VAT Tregs promotes adipose in fl ammation, insulin resistance, and hyperglycemia (16, 218, 222 – 224), while restoring their abundance via IL-2/IL-2 complexes or exogenous IL-33 reverses diabetogenic phenotypes in experimental models (16, 221).”
Metadata
- Authors
- Wu, D., Han, J. M., Yu, X., Lam, A. J., Hoeppli, R. E., Pesenacker, A. M., Huang, Q., Chen, V., Speake, C., Yorke, E., Nguyen, N., Sampath, S., Harris, D., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- Prevention of Organ Failure (CA)
- Benaroya Research Institute (US)
- Corresponding author
- Levings, Megan K.
- ORCID
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2019-01-08
- Volume
- 49
- Issue
- 2
- Pages
- 336-347
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2905083668
- Cited by
- 55
- References
- 44
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 9 · 2023: 3 · 2022: 6 · 2021: 11 · 2020: 8 · 2019: 6
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Canadian Diabetes Association (OG‐3‐14‐4460‐ML)
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- regulatory T cells, obesity, omental adipose tissue, visceral adipose tissue inflammation, type 2 diabetes, M1 macrophages, body mass index, Foxp3, CCR4, PPARγ, insulin resistance
- MeSH terms
- Adipose Tissue, Adult, Antigens, Differentiation, Diabetes Mellitus, Type 2, Female, Humans, Inflammation, Male, Obesity, Panniculitis, T-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.